Information on new approvals and medication safety that rheumatologists need to know
Prednisone Might be the Missing Ingredient in the American College of Rheumatology’s Recommendations for Treating Patients with Rheumatoid Arthritis
A combination therapy with glucocorticoids may be the gold standard for treating patients with rheumatoid arthritis (RA)
Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?
Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)
Why Oral Corticosteroids Should Not be Used in Patients with Rheumatoid Arthritis
Steroid use in patients with rheumatoid arthritis (RA) has been linked to higher mortality rates, greater rate of infections, more cases of pneumonia, and serious gastrointestinal events
Pain Treatment Will to Become More Targeted as Knowledge of Pain Mechanics Increases Bad
The notion of pain as just a peripheral, or strictly stimulus-driven, phenomenon is over.
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
ACR/ARHP Annual Meeting 2012: Cyclophosphamide and Rituximab Both Viable Treatment Options for ANCA-Associated Vasculitis
Rituximab established as the drug of choice in patients with severe disease relapse, though cyclophosphamide may still play an important role for some patients, say rheumatologists
New Hydrogel May Offer Promising Osteoarthritis Treatment
A new hydrogel that can be stretched and is self-healing might become an effective ligament repair option in osteoarthritis (OA).
Rheumatology Drug Updates
Information on new approvals and medication safety rheumatologists need to know
Rheumatology Drug Updates: Apremilast, Golimumab, and More
Information on new approvals and medication safety rheumatologists need to know
- « Previous Page
- 1
- …
- 113
- 114
- 115
- 116
- 117
- …
- 123
- Next Page »